Literature DB >> 9065425

Suppression of microtubule dynamics by LY290181. A potential mechanism for its antiproliferative action.

D Panda1, J P Singh, L Wilson.   

Abstract

LY290181, 2-amino-4-(3-pyridyl)-4H-naphtho(1,2-b)pyran-3-carbonitrile, is a potent antiproliferative compound that blocks cells in the G2/M phase of the cell cycle by an apparent action on microtubules. In the present work we found that LY290181 bound to tubulin with high affinity (1 mol of LY290181 per mol of tubulin dimer; Ka, 3.8 x 10(5) M-1) and that it did not appear to bind at the colchicine or vinblastine-binding sites. LY290181 strongly stabilized microtubule dynamics as determined by video microscopy. It reduced the rate and extent of growing and shortening, reduced the catastrophe frequency and increased the rescue frequency, and increased the percentage of time the microtubules spent in an attenuated state. At the lowest effective LY290181 concentrations (0.1-0.3 microM), suppression of dynamics occurred with little reduction in polymer mass. However, at higher concentrations, LY290181 strongly reduced the polymer mass with half-maximal inhibition at a concentration of 0.75 microM. We suggest that LY290181 may exert its antiproliferative activity by stabilizing spindle microtubule dynamics by binding to tubulin at a novel site.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065425     DOI: 10.1074/jbc.272.12.7681

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Antimicrotubular drugs binding to vinca domain of tubulin.

Authors:  Suvroma Gupta; Bhabatarak Bhattacharyya
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

2.  Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action.

Authors:  D Panda; H P Miller; K Islam; L Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 3.  Drugs that target dynamic microtubules: a new molecular perspective.

Authors:  Richard A Stanton; Kim M Gernert; James H Nettles; Ritu Aneja
Journal:  Med Res Rev       Date:  2011-03-04       Impact factor: 12.944

4.  Dynamin impacts homology-directed repair and breast cancer response to chemotherapy.

Authors:  Sophia B Chernikova; Rochelle B Nguyen; Jessica T Truong; Stephano S Mello; Jason H Stafford; Michael P Hay; Andrew Olson; David E Solow-Cordero; Douglas J Wood; Solomon Henry; Rie von Eyben; Lei Deng; Melanie Hayden Gephart; Asaithamby Aroumougame; Claudia Wiese; John C Game; Balázs Győrffy; J Martin Brown
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

5.  Crystal structure of ethyl 2-amino-4-(4-meth-oxy-phen-yl)-4H-1-benzothieno[3,2-b]pyran-3-carboxyl-ate.

Authors:  Mohamed Bakhouch; Abdelali Kerbal; Mohamed El Yazidi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-04-30

6.  Crystal structure of 2-amino-3-cyano-4-(4-meth-oxy-phen-yl)-4H-1-benzo-thieno[3,2-b]pyran.

Authors:  Mohamed Bakhouch; Mohamed El Yazidi; Abdelali Kerbal; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-12-12

7.  Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer Immunotherapy.

Authors:  Fumi Sato-Kaneko; Xiaodong Wang; Shiyin Yao; Tadashi Hosoya; Fitzgerald S Lao; Karen Messer; Minya Pu; Nikunj M Shukla; Howard B Cottam; Michael Chan; Dennis A Carson; Maripat Corr; Tomoko Hayashi
Journal:  Biomed Res Int       Date:  2018-10-10       Impact factor: 3.411

8.  Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions.

Authors:  Rawda M Okasha; Fawzia F Alblewi; Tarek H Afifi; Arshi Naqvi; Ahmed M Fouda; Al-Anood M Al-Dies; Ahmed M El-Agrody
Journal:  Molecules       Date:  2017-03-18       Impact factor: 4.411

9.  Introducing novel potent anticancer agents of 1H-benzo[f]chromene scaffolds, targeting c-Src kinase enzyme with MDA-MB-231 cell line anti-invasion effect.

Authors:  Hany E A Ahmed; Mohammed A A El-Nassag; Ahmed H Hassan; Rawda M Okasha; Saleh Ihmaid; Ahmed M Fouda; Tarek H Afifi; Ateyatallah Aljuhani; Ahmed M El-Agrody
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

10.  Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity.

Authors:  Maria V Yusenko; Abhiruchi Biyanee; Daria Frank; Leonhard H F Köhler; Mattias K Andersson; Cyrus Khandanpour; Rainer Schobert; Göran Stenman; Bernhard Biersack; Karl-Heinz Klempnauer
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.